CAR T-Cell Therapy | CHOP Research Institute
 

CAR T-Cell Therapy

Pediatric Cancer Survivorship Outcomes is a division-wide, outcomes-based clinical research program invested in creating a core community of CHOP and Penn researchers committed to improving the health of childhood cancer survivors across their lifespan.

Published on
Jun 7, 2024
CHOP receives a collaborative grant to drive cystic fibrosis research forward, Dr. John Maris honored with Pitcher of Hope Award, and more.

Dr. Laetsch is a pediatric oncologist who provides clinical care and conducts research with the overarching goal of improving treatment options for children with difficult to treat cancers.

E-mail:
laetscht [at] chop.edu